-+ 0.00%
-+ 0.00%
-+ 0.00%

Arrowhead Pharma Q1 Earnings Summary & Key Takeaways

Benzinga·02/05/2026 21:08:24
Listen to the news

Arrowhead Pharma (NASDAQ:ARWR) reported its Q1 earnings results on Thursday, February 5, 2026 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Arrowhead Pharma beat estimated earnings by 1000.0%, reporting an EPS of $0.22 versus an estimate of $0.02.

Revenue was up $261.53 million from the same period last year.

Previous Earnings Records

The company missed on EPS by $0.13 in the previous quarter, leading to a 23.34% increase share price change the next day.

Here's a look at Arrowhead Pharma's past performance:

Quarter Q4 2025 Q3 2025 Q2 2025 Q1 2025
EPS Estimate -0.05 -1.04 -0.46 -0.72
EPS Actual -0.18 -1.26 2.75 -1.39
Revenue Estimate 175.54M 33.78M 116.27M 19.05M
Revenue Actual 256.47M 27.77M 542.71M 2.50M

To track all earnings releases for Arrowhead Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.